Episodes 1-15 of 65
Advances in the Treatment and Management of MASH: More Options, More Decisions
CME/CE Live BroadcastAdvances in the Treatment and Management of MASH: More Options, More Decisions
October 26, 2024
08:00 PM - 09:30 PM EDT
The Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care
CME/CE Live BroadcastThe Changing Paradigm of Treating MASLD/MASH: At the Crossroads of Hepato-Cardiometabolic Care
November 16, 2024
08:00 PM - 09:30 PM PST
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient
CME/CE Live BroadcastAdvances in MASLD/MASH: Treating the Liver, the Disease, and the Patient
November 17, 2024
12:30 PM - 02:00 PM PST
Identifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
CME/CE Broadcast ReplayIdentifying the Great Imitator – Demystifying the Systemic Features of IgG4-Related Disease
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
MinuteCE®Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
IgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
CME/CEIgG4-RD Case Conversations: IgG4-related Autoimmune Pancreatitis and Cholangitis
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
CME/CEIgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
Navigating Treatment Paths: Selection and Sequencing in Biomarker-Driven Combination Regimens for First-Line G/GEJ Cancer Therapy
MinuteCE®Navigating Treatment Paths: Selection and Sequencing in Biomarker-Driven Combination Regimens for First-Line G/GEJ Cancer Therapy
Optimizing Treatment of Metastatic G/GEJ Cancers: Balancing Efficacy and Adverse Effects With Combination Regimens
MinuteCE®Optimizing Treatment of Metastatic G/GEJ Cancers: Balancing Efficacy and Adverse Effects With Combination Regimens
How Can a Multidisciplinary Team Optimize Management of G/GEJ Cancer–Related Symptom Burden?
MinuteCE®How Can a Multidisciplinary Team Optimize Management of G/GEJ Cancer–Related Symptom Burden?
Integrating Clinical Insights: Key G/GEJ Cancer Data Analyzed from the San Diego Oncology Conference
MinuteCE®Integrating Clinical Insights: Key G/GEJ Cancer Data Analyzed from the San Diego Oncology Conference
Multidisciplinary Approach to Diagnosing and Managing Indolent Systemic Mastocytosis: The Changing Landscape
CME/CEMultidisciplinary Approach to Diagnosing and Managing Indolent Systemic Mastocytosis: The Changing Landscape
